Viz.ai

📣 Exciting news! Viz.ai is collaborating with Microsoft to advance AI-powered clinical workflows. Together, Viz.ai One and Precision Imaging Network, part of Microsoft Cloud for Healthcare, bring more than 48 AI algorithms into clinical workflows, empowering healthcare teams to deliver actionable clinical insights and help improve patient outcomes. Learn more about how we’re transforming healthcare together at RSNA booth 4924. 👉 Read the press release here: https://lnkd.in/eAzGYuGa #AIinHealthcare #Vizai #MSFTHealth #RadiologyAI #CareCoordination #RSNA2024

We're looking forward to the J.P. Morgan Healthcare Conference in San Francisco 🌁 in the New Year. #JPM2025 Our leadership team  — Dr Chris Mansi, Jieun Choe, Tom Krohn, Bill Stadtlander, and Steve Sweeny — will be on hand to discuss AI’s potential for real-world patient impact. 📆 Schedule a meeting with us here: https://lnkd.in/gCmipm-K #PharmaAI #AIinPharma #JPMweek

In a world where every second matters, AI is reshaping medical imaging—speeding up workflows, optimizing resources, and improving patient outcomes. Tanya Dodge, Director of Imaging Services at HCA Midwest Health, dives into the real-world impact of AI in radiology. From reducing exam times to addressing staffing shortages, AI is not just a tool—it's a catalyst for a more efficient, patient-centered future. Read how advancements in AI are reshaping the healthcare landscape. https://lnkd.in/emWqcX3u #Radiology #HealthcareInnovation #PatientCare

Watch Dr Chris Mansi and Judy Khan Shaw's conversation on the NYSE trading floor for a #NYSEFloorTalk about Viz.ai's journey—scaling to 1,700+ hospitals, collaborating with 10 leading medical device and life sciences companies, and most importantly, increasing patient access to life-saving treatments.

We’re taking patient care to the next level by integrating Avicenna.AI's CINA-ASPECTS and CINA-iPE tools into the Viz.ai One™️platform. This collaboration helps clinicians interpret CT scans faster and more accurately to make informed treatment decisions for patients in need.  Learn how this partnership is reshaping patient care 👉 https://lnkd.in/eAjFGtDt

Advances in precision medicine have transformed care for NSCLC, improving outcomes but increasing complexity for oncologists who manage diverse cancer types. AI-powered “hubs” can simplify care by surfacing high-risk patients, personalized treatment options, and evidence-based guidelines. That's the future we're building at Viz.ai, alongside talented and patient-driven individuals like Steven Dalvin, MD, MBA, Director of Life Science Innovation 🚀 Learn more in his recent piece on the potential of AI in lung disease: https://lnkd.in/g9inW-zp

We're excited to kick off the new year in San Francisco 🌉  this January during JPM Week 2025 #JPM2025! #TeamViz will be in the city from January 13–16, connecting with pharma partners in the area. Let’s explore how we can collaborate to transform AI’s potential into real-world impact for patients that need your treatments. Reach out to connect ➡️ https://lnkd.in/gCmipm-K

Read the latest edition of Innovizion from Viz.ai — featuring our collaboration with Microsoft for Healthcare, our Prix Galien win for Viz HCM™, as well as news and articles from Viz and beyond. Read it here: https://lnkd.in/erHfuQDU Ps...Don’t miss our bi-monthly edition sent directly to your inbox. Subscribe now: https://lnkd.in/eqX7hJCW

We're delighted to announce that our CEO and Co-founder, Dr Chris Mansi, has been named to MM+M’s 40 Under 40 list—a program that honors the young talent working in and around medical marketing. “The individuals on the list are laying the foundation upon which the future of this industry will be built. They are creating a more equitable, inclusive landscape that will help pharma and biotech companies reach all patient populations,” said MM+M editor-in-chief Jameson Fleming. Learn more about this recognition and explore the full list of honorees here: https://lnkd.in/dhVpz2A

Our CEO & Co-Founder, Dr Chris Mansi, joined NYSE's Judy Khan Shaw for #NYSEFloorTalk to discuss how Viz.ai is transforming healthcare with AI. Chris shared our journey of scaling to 1,700+ hospitals and collaborating with 10 leading medical device and life sciences companies, including Bristol Myers Squibb and Medtronic. Highlighting our latest collaboration with Microsoft, Chris emphasized, “We’re excited to continue our mission to increase access to life-saving treatments.” 🎥 Watch the full interview now: https://lnkd.in/egQHGQcv